Prostacyclin receptor up-regulates the expression of angiogenic genes in human endometrium via cross talk with epidermal growth factor receptor and the extracellular signaling receptor kinase 1/2 pathway

Endocrinology

Volumn 147, Issue 4, 2006, Pages 1697-1705

  Milling Smith, Oliver P ^a   Battersby, Sharon ^a   Sales, Kurt J ^a   Critchley, Hilary O D ^a   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC PROTEIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; ILOPROST; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTACYCLIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; EPITHELIUM CELL; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; CELL LINE, TUMOR; ENDOMETRIUM; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; ILOPROST; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, EPOPROSTENOL; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 33645533814     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1073     Document Type: Article

References (42)

1. Narumiya S, FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30
2. Marnett LJ 1992 Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52:5575-5589
3. Narumiya S, Sugimoto Y, Ushikubi F 1999 Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226
4. Battersby S, Critchley HO, de Brum-Fernandes AJ, Jabbour HN 2004 Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle. Reproduction 127:79-86
5. Smyth EM, FitzGerald GA 2002 Human prostacyclin receptor. Vitam Horm 65:149-165
6. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Oh-ishi S, Narumiya S 1997 Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678-682
7. Ueno A, Naraba H, Ikeda Y, Ushikubi F, Murata T, Narumiya S, Oh-ishi S 2000 Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: a study on the paw edema induced in IP-receptor-deficient mice. Life Sci 66:155-160
8. 2) in excessive menstrual bleeding. Lancet 1:522-524
9. Gately S, Li WW 2004 Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin Oncol 31:2-11
10. 2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Endocrinol 18:1533-1545
11. 2α-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 65:7707-7716
12. Noyes RW, Hertig AT, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
13. 2α receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 89:986-993
14. Jabbour HN, Sales KJ 2004 Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 15:398-404
15. Wang H, Critchley HO, Kelly RW, Shen D, Baird DT 1998 Progesterone receptor subtype B is differentially regulated in human endometrial stroma. Mol Hum Reprod 4:407-412
16. Smith SK 2001 Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12:147-151
17. Smith SK, Abel MH, Kelly RW, Baird DT 1981 Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88:434-442
18. Sales KJ, Jabbour HN 2003 Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 71:97-117
19. Anderson AB, Haynes PJ, Guillebaud J, Turnbull AC 1976 Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Lancet 1:774-776
20. Cameron IT, Haining R, Lumsden MA, Thomas VR, Smith SK 1990 The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 76:85-88
21. 2α in epithelial cell proliferation. J Clin Endocrinol Metab 88:1825-1832
22. Lewis TS, Shapiro PS, Ahn NG 1998 Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139
23. Naor Z, Benard O, Seger R 2000 Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11:91-99
24. 2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457
25. Pai R, Nakamura T, Moon WS, Tarnawski AS 2003 Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17:1640-1647
26. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293
27. Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M 2003 Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res 63:5754-5760
28. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716
29. Kwabi-Addo B, Ozen M, Ittmann M 2004 The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 11:709-724
30. Bossard C, Van den Berghe L, Laurell H, Castano C, Cerutti M, Prats AC, Prats H 2004 Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide. Cancer Res 64:7507-7512
31. Mihalich A, Reina M, Mangioni S, Ponti E, Alberti L, Vigano P, Vignali M, Di Blasio AM 2003 Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis. J Clin Endocrinol Metab 88:2853-2859
32. Jabbour HN, Kelly RW, Fraser HM, Critchley HOD 2006 Endocrine regulation of menstruation. Endocr Rev 27:17-46
33. Baird DT, Cameron ST, Critchley HO, Drudy TA, Howe A, Jones RL, Lea RG, Kelly RW 1996 Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol 70:15-17
34. Hewett P, Nijjar S, Shams M, Morgan S, Gupta J, Ahmed A 2002 Down-regulation of angiopoietin-1 expression in menorrhagia. Am J Pathol 160:773-780
35. Blumenthal RD, Taylor AP, Goldman L, Brown G, Goldenberg DM 2002 Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium. Fertil Steril 78:1294-1300
36. Sangha RK, Li XF, Shams M, Ahmed A 1997 Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Lab Invest 77:389-402
37. Baker CH, Kedar D, McCarty MF, Tsan R, Weber KL, Bucana CD, Fidler IJ 2002 Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161:929-938
38. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM 2000 Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024-1028
39. Kooy J, Taylor NH, Healy DL, Rogers PA 1996 Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum Reprod 11:1067-1072
40. Hickey M, Fraser IS 2000 Clinical implications of disturbances of uterine vascular morphology and function. Baillieres Best Pract Res Clin Obstet Gynaecol 14:937-951
41. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG 2004 Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89:1089-1095
42. Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF 1996 Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 78:454-460